Qure.ai, mentioned 7 times across podcast episodes and expert conversations analyzed by Sonic.
Qure.ai has 65 of its AI-detected findings cleared for use in Europe via CE marking.
Qure.ai is currently in the process of obtaining FDA clearance for its wrist fracture detection solution.
The CREATE study demonstrated that Qure.ai's Lung Nodule Malignancy Risk Score has a sensitivity of over 95% for detecting lung cancer.